BGI Genomics Co Ltd (300676.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100003449
BGI Genomics Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.87 bn CNY | 3.71 bn CNY |
| Gross profit | 1.50 bn CNY | 1.39 bn CNY |
| Operating income | -874.77 m CNY | -169.97 m CNY |
| EBIT | -736.53 m CNY | -566.30 m CNY |
| Net income | -902.69 m CNY | -616.66 m CNY |
| Diluted EPS – continuing operations | -2.19 CNY | -1.47 CNY |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BGI Genomics Co Ltd
BGI Genomics Co., Ltd. engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally. The company offers DNA sequencing services comprising plant/animal/microbial whole genome re-sequencing and de novo sequencing; human whole genome sequencing, long-read human whole genome resequencing, and whole exome sequencing; epigenetics whole genome bisulfite sequencing and ChIp-Seq; and metagenomics and 16S/18S/ITS sequencing. It also provides RNA sequencing, long non-coding RNA sequencing, small RNA sequencing, iso-seq / pacbio transcriptome sequencing; single cell sequencing and high throughput single cell RNA-Seq; spatial transcriptome-stereo-seq; immune repertoire and pre-made library sequencing; and bioinformatics solutions. In addition, the company offers mass spectrometry, including proteomics, metabolomics, and multi-omics. Further, it provides clinical solutions for reproductive health, oncology, infectious disease, and chronic disease. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. The company was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd. operates as a subsidiary of BGI Group.
More stocks
- Shandong Humon Smelting Co Ltd (002237.SZ)
- Nuode Investment Co Ltd (600110.SS)
- Empresas CMPC (CMPC.SN)
- GN Store Nord A/S (GN.CO)
- H2O AMERICA (HTO)
- Flywire Corp (FLYW)
- V2X, Inc. (VVX)
- Alleima AB (ALLEI.ST)
- Pacific Basin Shipping Ltd (2343.HK)
- Macrolink Real Estate Co Ltd (000620.SZ)
- DUCOMMUN INC /DE/ (DCO)
- BANNER CORP (BANR)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.